Publication | Open Access

Optimization of in vivo tumor targeting in SCID mice with divalent forms of 741F8 anti-c-erbB-2 single-chain Fv: effects of dose escalation and repeated i.v. administration

Drug TargetingDose EscalationImmunologyScid MiceTumor TargetingAnti-cancer AgentCancer TreatmentVivo TumorRadiation OncologyMedicineCell BiologyCancer ResearchNovel TherapyTumor Biology